TotalMarketCap

Sunshine Biopharma

SBFMNasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.161 M

$2.84 +7.17%

Close of 6 Nov 2026

As of 6 Nov 2026, Sunshine Biopharma (SBFM) has a market capitalization of $2.16M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$36.3M

#2814 by revenue

Earnings

-$5.98M

Loss-making

Shares outstanding

3,877,337

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Sunshine Biopharma lists more than one class of stock. Company figures above cover all classes combined.

SBFMW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #479Galmed PharmaceuticalsEOCN$2.55M
  2. #480HCW BiologicsHCWB$2.30M
  3. #481Sunshine BiopharmaSBFM$2.16M
  4. #482Revelation BiosciencesREVB$2.03M
  5. #483Purple BiotechPPBT$2.02M

What if Sunshine Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$37,106,418

Per share 13,065,640× higher

Bitcoin $1.53T

$2,007,764

Per share 706,959× higher

Apple $5.02T

$6,591,301

Per share 2,320,881× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Sunshine Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.